4.6 Article

Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent

Bruna Pellini et al.

Summary: Circulating tumor DNA minimal residual disease is a powerful biomarker with the potential to improve survival outcomes for non-small-cell lung cancer. Although the current studies are limited in size, largely retrospective, and without thorough prospective clinical validation, the detection of ctDNA minimal residual disease has shown good sensitivity and specificity at the first post-treatment timepoint, and improved performance in surveillance.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine

Melanie Pages et al.

Summary: The study systematically evaluated the feasibility of profiling pediatric brain tumors using ctDNA obtained from plasma, CSF, and urine. Results showed that most samples had very low levels of somatic mutations, posing a challenge for detection using whole-genome or targeted sequencing methods. Substantial challenges remain in genetically characterizing pediatric brain tumors from liquid biopsies.

NEURO-ONCOLOGY (2022)

Article Oncology

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients

Alexandra M. Miller et al.

Summary: The study utilized CSF cell-free DNA for molecular diagnostics and found a correlation between positivity and disseminated disease in patients. The testing provided diagnostic and therapeutic information, which is crucial for the care of pediatric and adolescent patients.

NEURO-ONCOLOGY (2022)

Article Oncology

Precision medicine in pediatric solid cancers

Mirjam Blattner-Johnson et al.

Summary: Despite advances in diagnosing and treating pediatric cancers, it remains a leading cause of childhood death in developed countries. The heterogeneity of tumor types in children, which differ from adult carcinomas, has made understanding the underlying biology and developing targeted treatments difficult. Additionally, the pharmaceutical industry has been reluctant to develop products for this population due to market size. However, recent changes in science and regulation are addressing these challenges.

SEMINARS IN CANCER BIOLOGY (2022)

Review Oncology

Clinical utility of whole-genome sequencing in precision oncology

Richard Rosenquist et al.

Summary: Precision diagnostics is an important aspect of precision medicine, and whole-genome sequencing can be used to predict and respond to cancer treatment. National initiatives aim to introduce clinical whole-genome sequencing as a rational and effective diagnostic tool, but there is a lack of systematic evaluation of the clinical utility of whole-genome sequencing.

SEMINARS IN CANCER BIOLOGY (2022)

Letter Biochemistry & Molecular Biology

Implementing precision medicine in a regionally organized healthcare system in Sweden

Thoas Fioretos et al.

NATURE MEDICINE (2022)

Article Oncology

CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018

Quinn T. Ostrom et al.

Summary: The CBTRUS Statistical Report provides a comprehensive description of the incidence rate of brain and other CNS tumors in children and adolescents in the United States. This report is a valuable resource for researchers, clinicians, patients, and families.

NEURO-ONCOLOGY (2022)

Article Oncology

Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care

Edwin Cuppen et al.

Summary: The combination of whole-genome and transcriptome sequencing (WGTS) is a comprehensive precision diagnostic test that is expected to transform diagnosis and treatment for cancer patients. However, there are barriers to the implementation and widespread adoption of this test, including considerations of utility in different cancer types, cost-effectiveness and affordability.

JCO PRECISION ONCOLOGY (2022)

Article Oncology

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Anthony P. Y. Liu et al.

Summary: The study demonstrates the clinical utility of CSF-derived cell-free DNA (cfDNA) as a biomarker of measurable residual disease (MRD) in children with medulloblastoma. Detection of MRD, particularly in patients with persistent MRD, is associated with a higher risk of disease progression. Early detection of MRD using liquid biopsies may aid in monitoring disease progression and treatment efficacy in medulloblastoma patients.

CANCER CELL (2021)

Article Oncology

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar et al.

Summary: The study identified new risk stratification for medulloblastoma treatment through molecular classification and risk factor analysis, finding differences in PFS among patients with different genotypes and subtypes.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma

Martin Mynarek et al.

Summary: The SIOP PNET5 MB trial, initiated in 2014, stratifies treatments for childhood medulloblastoma based on clinical, histological, and molecular parameters. It investigates different treatment strategies for standard-risk and favourable-risk strata, showing feasibility of using biological parameters for stratification and potential for improving future treatment outcomes.

CANCERS (2021)

Review Oncology

Cognitive Risk in Survivors of Pediatric Brain Tumors

Ade Oyefiade et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

PRMT7 methylates and suppresses GLI2 binding to SUFU thereby promoting its activation

Tuan Anh Vuong et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Medicine, General & Internal

Medulloblastoma

Paul A. Northcott et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Article Biochemistry & Molecular Biology

COSMIC: the Catalogue Of Somatic Mutations In Cancer

John G. Tate et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemistry & Molecular Biology

ClinVar: improving access to variant interpretations and supporting evidence

Melissa J. Landrum et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

The landscape of genomic alterations across childhood cancers

Susanne N. Groebner et al.

NATURE (2018)

Article Multidisciplinary Sciences

DNA methylation-based classification of central nervous system tumours

David Capper et al.

NATURE (2018)

Article Oncology

Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013

Vishesh Khanna et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Article Multidisciplinary Sciences

The whole-genome landscape of medulloblastoma subtypes

Paul A. Northcott et al.

NATURE (2017)

Review Oncology

Variant Review with the Integrative Genomics Viewer

James T. Robinson et al.

CANCER RESEARCH (2017)

Review Oncology

Liquid biopsies come of age: towards implementation of circulating tumour DNA

Jonathan C. M. Wan et al.

NATURE REVIEWS CANCER (2017)

Article Biochemical Research Methods

MultiQC: summarize analysis results for multiple tools and samples in a single report

Philip Ewels et al.

BIOINFORMATICS (2016)

Article Biotechnology & Applied Microbiology

The Ensembl Variant Effect Predictor

William McLaren et al.

GENOME BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Functional characterization of enzymes catalyzing ceramide phosphoethanolamine biosynthesis in mice

Andreas Bickert et al.

JOURNAL OF LIPID RESEARCH (2015)

Article Multidisciplinary Sciences

Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

Yuxuan Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Multidisciplinary Sciences

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Leticia De Mattos-Arruda et al.

NATURE COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

FOSL2 Positively Regulates TGF-β1 Signalling in Non-Small Cell Lung Cancer

Junfeng Wang et al.

PLOS ONE (2014)

Article Cell Biology

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Chetan Bettegowda et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Clinical Neurology

The Role of Chromatin Remodeling in Medulloblastoma

David T. W. Jones et al.

BRAIN PATHOLOGY (2013)

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Article Clinical Neurology

Molecular subgroups of medulloblastoma: the current consensus

Michael D. Taylor et al.

ACTA NEUROPATHOLOGICA (2012)

Article Multidisciplinary Sciences

Novel mutations target distinct subgroups of medulloblastoma

Giles Robinson et al.

NATURE (2012)

Article Multidisciplinary Sciences

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Paul A. Northcott et al.

NATURE (2012)

Article Oncology

Functional characterization of the 19q12 amplicon in grade III breast cancers

Rachael Natrajan et al.

BREAST CANCER RESEARCH (2012)

Article Multidisciplinary Sciences

Allele-specific copy number analysis of tumors

Peter Van Loo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Circulating mutant DNA to assess tumor dynamics

Frank Diehl et al.

NATURE MEDICINE (2008)

Article Biochemistry & Molecular Biology

Primer3Plus, an enhanced web interface to Primer3

Andreas Untergasser et al.

NUCLEIC ACIDS RESEARCH (2007)